Drug Profile
Nivazole
Alternative Names: NEBO 174; NovozolaLatest Information Update: 28 Jul 2006
Price :
$50
*
At a glance
- Originator Neuro Bioscience
- Class
- Mechanism of Action Glucocorticoid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 28 Jul 2006 No development reported - Phase-I for Depression in USA (unspecified route)
- 20 Jun 2003 Phase-I clinical trials in Depression in USA (unspecified route)